Brief: India's Bharat Immunologicals and Biologicals Corp March-qtr profit surges
May 5 (Reuters) - Bharat Immunologicals and Biologicals
Corporation Ltd BIBC.BO
* March quarter net profit 40.8 million rupees versus
profit9.6 million rupees year ago
* March quarter net sales 613.4 million rupees versus 589.9
million rupees year ago
Source text: (http://bit.ly/2pcHXHG)
Further company coverage: BIBC.BO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Bharat Immunologicals and Biologicals
See all newsEU countries agree to admit travellers vaccinated with WHO-approved shots
EU proposes booster jabs for 2022 travel, opens to WHO vaccines (updated)
Refinitiv Newscasts - Asia Insight: India plans refiners' joint oil deals to cut import bill
Brazil police raid pharmaceutical firm amid Senate vaccine probe
Media: Bharat Bio begins first phase of human trials of Covaxin - Economic Times